- Nutrition and Huntington's Disease- A Review of Current Practice and Theory
- Understanding glucose metabolism and insulin action at the blood-brain barrier: Implications for brain health and neurodegenerative diseases
- Neuroinflammation and neurodegeneration in Huntington's disease: genetic hallmarks, role of metals and organophosphates
- Estimating disease onset distribution functions in mutation carriers with censored mixture data
- Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders
- Longitudinal Treatment Patterns of Chorea in North American Patients with Huntington's Disease: Data from Enroll-HD
- Total functioning capacity scale in Huntington's disease: natural course over time
- In Vivo Nanodiamond Quantum Sensing of Free Radicals in Caenorhabditis elegans Models
- Disease-Specific Speech Movement Characteristics of the Tongue and Jaw
- Bioinformatics Analysis Reveals Microrchidia Family Genes as the Prognostic and Therapeutic Markers for Colorectal Cancer
- Foreign Contaminants Target Brain Health
- TRANSIENT ALTERATIONS IN THALAMO-CEREBELLAR FUNCTIONAL CONNECTIVITY IN PREMANIFEST HUNTINGTON'S DISEASE
- Targeting mitophagy in neurodegenerative diseases
- Small CAG Repeat RNA Forms a Duplex Structure with Sticky Ends That Promote RNA Condensation
- Unraveling the transcriptomic landscape of brain vascular cells in dementia: A systematic review
- Current Status and Future Perspective of Seoul National University Hospital-Dementia Brain Bank with Concordance of Clinical and Neuropathological Diagnosis
- The Emerging Role of Mitochondria Oxygen Redox in Pathological Progression of Neurodegenerative Disorders
- RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington's disease models
- Effect of Triheptanoin on Caudate Atrophy and Motor Scores in Patients With Early-Stage Huntington Disease: A Phase II Study
- Genomic characterization of Huntington's disease genetic modifiers informs drug target tractability
- QOMIC: quantum optimization for motif identification
- Oxidative/Nitrosative Stress, Apoptosis, and Redox Signaling: Key Players in Neurodegenerative Diseases
- The role of mitochondrial remodeling in neurodegenerative diseases
- Determining the effects of transcranial alternating current stimulation on corticomotor excitability and motor performance: A sham-controlled comparison of four frequencies
- Impact of Upper Limb Function on Activities of Daily Living and Quality of Life in Huntington's Disease
- Movement Disorders and Smart Wrist Devices: A Comprehensive Study
- Calcium Signalling in Neurological Disorders, with Insights from Miniature Fluorescence Microscopy
- Advances in Stem Cell Therapy for Huntington's Disease: A Comprehensive Literature Review
- Msh2-Msh3 DNA-binding is not sufficient to promote trinucleotide repeat expansions in Saccharomyces cerevisiae
- White Matter Changes in Alzheimer's and Treated Huntington's Disease Mouse Models Detected by Diffusion MRI
- White Matter Changes in Alzheimer's and Treated Huntington's Disease Mouse Models Detected by Diffusion MRI
- A collaborative network analysis for the interpretation of transcriptomics data in Huntington's disease
- Biomarkers
- Biomarkers
- Biomarkers
- Alzheimer's Imaging Consortium
- Developing Topics
- Biomarkers
- Biomarkers
- Biomarkers
- Biomarkers
- Effects and mechanisms of computerized cognitive training in Huntington's disease: protocol for a pilot study
- Drug Development
- Intermittent Fasting Enhances Motor Coordination Through Myelin Preservation in Aged Mice
- Age-dependent alterations in the head-direction signal in a rat model of Fragile X Syndrome
- Regulation of mutant huntingtin mitochondrial toxicity by phosphomimetic mutations within its N-terminal region
- Ubiquitin specific peptidase 11 knockdown slows Huntington's disease progression via regulating mitochondrial dysfunction and neuronal damage depending on PTEN-mediated AKT pathway
- Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine
- Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets
- APOBEC3A deaminates CTG hairpin loops to promote fragility and instability of expanded CAG/CTG repeats
- The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases
- Evaluation of an Antisense Oligonucleotide Targeting CAG Repeats: A Patient-Customized Therapy Study for Huntington's Disease
- Epigenetic Modifiers: Exploring the Roles of Histone Methyltransferases and Demethylases in Cancer and Neurodegeneration
- Mechanisms and Potential Benefits of Neuroprotective Agents in Neurological Health
- Huntingtin interactome reveals huntingtin role in regulation of double strand break DNA damage response (DSB/DDR), chromatin remodeling and RNA processing pathways
- Anti-gene oligonucleotide clamps invade dsDNA and downregulate <em>huntingtin</em> expression
- A supercritical oil extract of Schisandra chinensis seeds ameliorates Huntington's disease-like symptoms and neuropathology: the potential role of anti-oxidant and anti-inflammatory effects
- Intrastriatal delivery of a zinc finger protein targeting the mutant HTT gene obviates lipid phenotypes in zQ175DN HD mice
- Aberrant splicing in Huntington's disease accompanies disrupted TDP-43 activity and altered m6A RNA modification
- Association of real life postural transitions kinematics with fatigue in neurodegenerative and immune diseases
- Pharmacogenomics for neurodegenerative disorders - a focused review
- Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET study
- Roles of SIRT3 in cardiovascular and neurodegenerative diseases
- Basic Science and Pathogenesis
- Basic Science and Pathogenesis
- Basic Science and Pathogenesis
- Breaking Barriers in Huntington's Disease Therapy: Focused Ultrasound for Targeted Drug Delivery
- The joint memory effect: challenging the selfish stigma in Huntington's disease?
- Preserved social facilitation and preferential processing of partner-relevant information in Huntington's disease
- Autophagy receptor-inspired chimeras: a novel approach to facilitate the removal of protein aggregates and organelle by autophagy degradation
- Genetically Engineered Mouse Models for Alzheimer Disease and Frontotemporal Dementia: New Insights from Single-Cell and Spatial Transcriptomics
- Detection of HTTex1p by western blot and immunostaining of HD human and mouse brain using neo-epitope antibody P90 highlights impact of CAG repeat expansion on its size, solubility, and response to MSH3 silencing
- The Use of Cannabis-Based Medicine in Selected Neurological Disorders
- Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease
- Decoding TDP-43: the molecular chameleon of neurodegenerative diseases
- Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease
- Validation of the Korean Version of the Huntington's Disease Quality of Life Battery for Carers
- Location of polyglutamine track affects pathogenic threshold of polyglutamine expansion diseases - Importance of association with the proteasome
- Tapetum specific TA29 promoter is regulated by cis- elements binding to positive and negative regulators
- Huntingtin interactome reveals huntingtin role in regulation of double strand break DNA damage response (DSB/DDR), chromatin remodeling and RNA processing pathways
- Valbenazine for the treatment of chorea associated with Huntington's disease
- Biodistribution and dosimetry of the PET radioligand [<sup>18</sup>F]CHDI-650 in mice for detection of mutant huntingtin aggregates
- Sciadopitysin from Taxus chinensis as a potential therapeutic agent for Huntington's disease
- Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut-Brain Axis and <em>Helicobacter pylori</em> Infection
- Sex-Dependent Efficacy of Sphingosine-1-Phosphate Receptor Agonist FTY720 in Mitigating Huntington's Disease
- A practical guide for diagnostic investigations and special considerations in patients with Huntington's disease in Korea
- Systematic Benchmarking of High-Throughput Subcellular Spatial Transcriptomics Platforms
- Synaptic modulation of glutamate in striatum of the YAC128 mouse model of Huntington disease
- "A patent review on arachidonic acid lipoxygenase (LOX) inhibitors for the treatment of neurodegenerative diseases (2018-present)"
- Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays
- Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease
- Dual Infrared 2-Photon Microscopy Achieves Minimal Background Deep Tissue Imaging in Brain and Plant Tissues
- Engineered biological neural networks as basic logic operators
- Mouse brain organoids model in vivo neurodevelopment and function and capture differences to human
- Recent advances in stem cell therapy: efficacy, ethics, safety concerns, and future directions focusing on neurodegenerative disorders - a review
- Clinical experience and treatment considerations with vesicular monoamine transport 2 inhibitors
- Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators
- Hijacking intercellular trafficking for the spread of protein aggregates in neurodegenerative diseases: a focus on tunneling nanotubes (TNTs)
- Advances and Challenges in Gene Therapy for Neurodegenerative Diseases: A Systematic Review
- Potential Protective Effects of Pungent Flavor Components in Neurodegenerative Diseases
